Stock Analysis on Net

Philip Morris International Inc. (NYSE:PM)

$24.99

Common-Size Income Statement
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

  • Get full access to the entire website from $10.42/mo, or

  • get 1-month access to Philip Morris International Inc. for $24.99.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Philip Morris International Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net revenues
Cost of sales
Gross profit
Marketing, administration and research costs
Impairment of goodwill
Operating income
Interest expense, net
Pension and other employee benefit costs
Earnings before income taxes
Provision for income taxes
Impairment related to the RBH equity investment
Equity investments and securities income (loss), net
Net earnings
Net earnings attributable to noncontrolling interests
Net earnings attributable to PMI

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


The financial data under review exhibits fluctuations in profitability and cost management across the observed quarters. Several key trends and shifts in financial ratios relative to net revenues warrant detailed attention.

Cost of Sales
The cost of sales as a percentage of net revenues shows variability, initially ranging mostly between approximately -29.98% and -34.64% in 2020 and 2021. From 2022 onward, there is an observable increase in cost severity peaking near -39.39% toward late 2022. Subsequently, a gradual improvement occurs with costs decreasing to around -32.34% by mid-2025, indicating some recovery or better cost control in later periods.
Gross Profit
Gross profit margins correspond inversely with cost of sales movements. Margins improved to over 70% in early 2021 but then declined steadily through late 2022 to a low near 60.61%. Post-2022, there is a recovery trend where gross profit margins rise again, reaching approximately 67.66% by mid-2025, suggesting improved profitability at the gross level after a period of pressure.
Marketing, Administration, and Research Costs
Operating expenses classified under marketing, administration, and research present moderate oscillations. These costs fluctuate mostly between -23.75% and -31.16% over the quarters, with a tendency to increase as a proportion of revenues toward the later periods, particularly in 2024 and 2025. This upward pressure on expenses could weigh on operating results if not matched by revenue growth.
Impairment Charges
Impairment of goodwill appears as a significant negative impact starting in mid-2023, reaching -7.42% of net revenues in that quarter and moderating somewhat later. Additionally, an impairment related to an equity investment notably impacts late 2024 results with a sharp -23.86% reduction. Such large impairments represent episodic losses affecting profitability distinctly in those periods.
Operating Income
Operating income as a percent of net revenues moves broadly between approximately 28.62% to 45.41%. The highest operating margin occurs in the first quarter of 2021. However, there is notable volatility, in particular a dip to about 28.62% in mid-2023 corresponding to increased impairments and operating costs. Recovery phases are visible toward 2025, suggesting ongoing operational adjustments.
Interest Expense and Other Costs
Interest expense relative to revenues fluctuates mostly within a narrow band around -1.8% to -3.4%, showing some increase in cost of debt financing or related expenses especially between 2023 and 2025. Pension and employee benefit costs remain quite minor, generally below -0.4%, reflecting limited impact on overall profitability from such expenses.
Earnings Before Income Taxes (EBIT)
EBIT margins parallel operating income trends, with peaks exceeding 42% and declines to mid-20% levels during the more challenging periods. Earnings before taxes show a reduction during mid-2023 to early 2024, in line with impairments and higher operational costs, before partially recovering toward the later quarters.
Income Taxes
The provision for income taxes as a percentage of net revenues varies significantly, from a low near -3.54% to highs around -11.28%, without a clear directional pattern. The variability in tax expense may reflect changes in profitability, tax rates, or other factors like deferred tax impacts tied to impairments and earnings volatility.
Equity Investments and Securities Income
The net impact of equity investments and securities income demonstrates variability with positive contributions in several quarters, notably reaching as high as 5.04% in late 2024. However, some quarters reflect negative impacts, indicating fluctuating gains or losses from investments which contribute to overall profitability fluctuations.
Net Earnings
Net earnings attributable to the entity exhibit a general pattern of variability consistent with operational and impairment impacts. Earnings started at around 27.78% of revenues in early 2020, peaked near 34.21% in early 2021, and showed a weak period mid-2023 with a trough near 18.76%. Despite this, net earnings show recovery signs toward early and mid-2025, surpassing 30% in some quarters. A notable outlier is the sharp negative net earnings of -5.01% in the first quarter of 2025, likely linked to the large impairment recorded.
Net Earnings Attributable to Noncontrolling Interests
The share of net earnings attributable to noncontrolling interests remains relatively steady, mostly between -0.96% and -2.33%, indicating a consistent minority interest impact without marked fluctuations over the periods.
Overall Insight
The data reveals a cycle of operational strength followed by cost pressures and impairment charges, influencing profitability outcomes. The company experiences a phase of elevated cost of sales and impairments impacting margins in 2022 and 2023, but subsequent quarters show signs of stabilization and recovery in operating efficiencies and earnings. Financial and investment income volatility contributes additional variability to net earnings. Attention to cost controls and managing impairment risks will likely be crucial for future margin sustainability.